$PRQR

ProQR Therapeutics N.V

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.66 ▼-2.092%

Extented Hours

VOLUME

236,691

DAY RANGE

0.6037 - 0.6799

52 WEEK

0.53 - 9.09

Join Discuss about PRQR with like-minded investors

profile
@dros #droscrew
recently

Upgrades 2/14: $ALL $ASND $BE $BXSL $CMA $DFS $GT $MU $OSCR $ST $TGI $TREX $TU $WSO $ZION . Downgrades 2/14: $AGNC $CRNC $CVS $G $IAA $JPM $NLY $PGR $PRQR $TSN $TXN $USB $ZEN

134 Replies 13 👍 6 🔥

SO
@soheil.n #StockTraders.NET
recently

IU Watchlist: Main Watches: $F higher better looking to fade 945-10AM + nice one today off open fade. $CEI pretty good anticipation of range last night goal was $3.50-4 ($3.44 intraday 3.48 hit AHs) close enough? I have a feeling this one is going to be tough tomorrow. I think we have a weak open and I think we turn on SSR and everyone spends the AM shorting and just sorta is a pain in the ass to trade. IDEAL trade would be $3.50-4 parabolic and sit back - there's definitely a fund toying around with this thing and social media being the mouth piece. Like I talked about with Sunday video - at some point you just have to realize that the movement is working and reality doesn't matter - not to mention everyone wants the same thing so as a trade you must be one step ahead like today. Nice work in the room. $AMD 945-10AM + trend join nice range Failed Follow Through: $SNOA morning shove looking to continue to fade these. $DATS was actually a really nice trader today BUT if things are going sideways if things flush out you need to EXPECT at this point there will be a swipe at any point in time that could turn this thing on a dime. That's what kind of market we are in. If you trade the big moves and cover the flushes this has been a nice trader. I'd love to see a circuit halt or two and then a decent trade probably asking for too much though. $ALF ideally forgotten tomorrow and off radar. $MRIN same as ALF. $DBGI pretty clean one today from fails - let it work as long as I could and still covered too early. Morning shove and looking to fade it more. Continuation: $GREE big PT AHs $78 could be 4AM ripper then get some newsletters on it and dance pre market. Would love to see it get some vol and jump into circuits - maybe asking too much but it's been straight down w/ zero bounce it deserves one day of wild. $DOGZ joined trend today. $PRQR chart shaping back up $AIKI joined today so so -- figured it'd be stronger I guess it was rocking late day wasn't really watching it since it was a big picture idea but came in off the mid .9x's. If it can't base .88-.90 next few days I'll move along.

73 Replies 10 👍 13 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, September 9, 2021 Following a day of weakness, U.S. stock futures are again looking modestly lower, pulling back along with declines in both Europe and Asia as the spread of the delta strain of Covid-19 continues to weigh on the U.S. economy. This morning, two airlines noted impact to revenues due to a decline in travel. Tech stocks in China fell after regulators again increased pressure on gaming companies for focusing solely on profit. In Asian markets, The Nikkei Index declines -173 points to hold just above 30K, the Shanghai Index rose 17 points to 3,693 and the Hang Seng Index dropped over -600 points (2.3%) to settle at 25,716. In Europe, the German DAX is down about -40points to 15,570, while the FTSE 100 tumbles over -80 points (1.2%) to hold around the 7,000 level. Yesterday, Europe’s Stoxx 600 was down 1.0%, marks worst day in nearly 3 weeks as the German Dax down 1.4%, marks worst day since mid-July. Later this morning, we get the European Central Bank (ECB) rate decision at 7:45 AM and press conference at 8:30 AM where investors will look for clues about inflation and or asset tapering. The S&P 500 Index was lower for a third straight session Wednesday amid increasing concerns about economic growth and the ongoing spread of Covid. The Federal Reserve’s Beige Book report showed that economic growth downshifted slightly to a moderate pace from early July through August, largely due to a pullback in dining out, travel and tourism because of consumers’ safety fears. The dollar pared earlier gains, while Treasuries recovered Tuesday’s losses. Market Closing Prices Yesterday · The S&P 500 Index slipped -5.96 points, or 0.13%, to 4,514.07 · The Dow Jones Industrial Average fell -68.93 points, or 0.20%, to 35,031.07 · The Nasdaq Composite dropped -87.69 points, or 0.57%, to 15,286.64 · The Russell 2000 Index declined -25.88 points, or 1.14% to 2,249.73 Events Calendar for Today · 8:30 AM ET Weekly Jobless Claims · 8:30 AM EST Continuing Claims · 10:30 AM ET Weekly EIA Natural Gas Inventory Data · 11:00 AM ET Weekly DOE Inventory Data Earnings Calendar: · Earnings Before the Open: ASO, HOFT, HOV, JILL, LOVE, TUESQ · Earnings After the Close: AFRM, AMRK, AOUT, COOK, CXM, FARM, KLXE, LAKE, PLAY, PWSC, SUMO, VRNT, ZS, ZUMZ Other Key Events: · Barclay’s Global Consumer Staples Conference (virtual) 2021, 9/8-9/10 · Barclay’s CEO Energy-Power Conference 2021 (virtual), 9/8-9/10 · BTIG Cloud Communications and Collaboration Investor Forum (virtual), 9/8 · Citigroup Annual BioPharma Conference (virtual), 9/8-9/10 · Citigroup GEMS Conference 2021 (virtual), 9/8-9/10 · Cowen 14th Annual Global Transportation & Sustainable Mobility Conference, 9/8-9/10 · Credit Suisse 2021 Global Steel & Mining Conference (virtual), 9/8-9/10 · Stephens Building Materials Investor Trip, 9/8-9/9 · Wolfe Inaugural TMT Conference, 9/8-9/9 · Barrington Annual Fall Investment Conference (virtual), 9/9 · DA Davidson Annual Software & Internet Conference (virtual), 9/9 · Deutsche Bank 2021 Technology Conference (virtual), 9/9-9/10 · Goldman Sachs 11th Annual Financial Technology Conference (virtual), 9/9 · Needham 1st Annual Needham Crypto Conference (virtual), 9/9 · Wells Fargo 2021 Healthcare Conference (virtual), 9/9-9/10 Sector News Breakdown Consumer · Lululemon ($LULU) shares rise 10%; 2Q adj EPS $1.65 vs est. $1.19 on revs $1.5B vs est. $1.33B; guides 3Q adj EPS $1.33-1.38 vs est. $1.32, sees 3Q revs $1.4-1.43B vs est. $1.32B; guides FY adj EPS $7.38-7.48 vs est. $6.91; raises year revs to range of $6.19B-$6.26B, compared with its prior range of $5.83B-$5.91B · RH Corp. ($RH) 2Q adj EPS $8.48 vs est. $6.48 on revs $989Mm vs est. $975.5Mm; guides FY revs +31-33% up from prior 25%-30% view and vs est. +29.2% and op margin 24.9-25.5% , sees ROIC 70% vs prior 60%; says currently expecting manufacturing to restart in Vietnam in October with full capacity by end of year · Boston Beer Company Inc ($SAM) shares fell -8%; said since last guidance update market for hard seltzer products has continued to experience decelerating growth trends; believe there will be continuing uncertainty about hard seltzer demand trends for remainder of 2021; said it is withdrawing its 2021 financial guidance issued on July 22, 2021 as EPS will fall below previously-reported estimate of between $18.00-$22.00 · Caesars ($CZR) announced an agreement to sell the non-US assets of William Hill to 888 Holdings for approximately GBP 2.2B · Copart (C$PRT) Q4 non-GAAP EPS $1.03 vs. est. $0.91; Q4 revs $748.6M vs. est. $690.87M · VICI Properties ($VICI) announces offering of 100M shares of common stock · GameStop ($GME) Q2 EPS loss (-$0.76) vs. est. loss (-$0.67); Q2 revs $1.183B vs. est. $1.12B; Ended the period with cash and restricted cash of $1.78B · Calavo Growers ($CVGW) 3Q adj EPS ($0.17) vs est. ($0.05) on revs $285Mm vs est. $281.7Mm · Limoneira ($LMNR) Q3 adj EPS $0.20 vs. est. $0.18; Q3 revs $49.1M vs. est. $48.8M; Agribusiness revenue Q3 includes $24.4M in fresh lemon sales, compared to $35.4M of fresh lemon sales during the same period of fiscal year 2020; approximately 1,144,000 cartons of fresh lemons were sold in aggregate · Torrid ($CURV) 2Q adj EPS $0.36 vs est. $0.16 on sales $332.9Mm vs est. $294.7Mm; guides 3Q sales $305-315Mm vs est. $305.1Mm; guides FY sales $1.29-1.31B vs est. $1.3B Energy, Industrials and Materials · The American Petroleum Institute ($API) reports that crude inventories fell 2.88M barrels last week and gasoline inventories fell 6.41M barrels · United Airlines ($UAL) said it expects third-quarter capacity to fall at least 28% compared with the same period in 2019, as bookings take a hit due to the rise in COVID-19 cases fueled by the Delta variant. · Southwest Airlines ($LUV) said it sees October operating revenue down 20% to 30% vs 2019; expects q4 2021 capacity to increase about 60% YoY and to decrease about 5% vs. Q4 2019 · Sherwin-Williams ($SHW), Axalta Coating (AXTA), and PPG Industries (PPG) all downgraded to Neutral from Buy at Citigroup · ABM Industries ($ABM) Q3 revenue $1.54B vs. est. $1.51B; Q3 EPS from continuing operations $0.90 vs. est. $0.81; sees FY adj eps cont ops $3.45 to $3.55, vs. prior view $3.30 to $3.50 · AeroVironment ($AVAV) Q1 adj EPS loss (-$0.17) vs. est. loss (-$0.24); Q1 revs $101M vs. est. $96.48M; backs FY22 adj EPS view $2.50-$2.70 (est. $2.64) and backs FY22 revenue view $560M-$580M (est. $569.34M) Financials · Digital Realty ($DLR) 6.25M share Spot Secondary priced at $160.50 · Riot Blockchain ($RIOT) produces 441 Bitcoins in August, down from the 444 BTC produced in July; on a Y/Y basis, its production increased 451% from 80 BTC in August 2020. Healthcare · Humanigen ($HGEN) plunges over 50% after U.S. FDA declines emergency use approval for COVID-19 drug; said the FDA declined to grant emergency use authorization for its drug, lenzilumab, to treat patients hospitalized with COVID-19 · ProQR Therapeutics ($PRQR) announces a global licensing and research collaboration with Eli Lilly (LLY) to discover new medicines for genetic disorders in the liver and nervous system, in a deal that could be worth over $1.25B · Avid Biosciences ($CDMO) Q1 EPS $0.10 vs. est. $0.04; Q1 revs $30.8M vs. est. $27.8M; · HealthEquity Corp. ($HQY) 2Q adj EPS $0.40 vs est. $0.36 on revs $189.1Mm vs est. $184.7Mm; guides FY adj EPS $1.45-1.50 vs est. $1.49, sees FY revs $755-765Mm vs est. $762.8Mm; says re: WageWorks have achieved approximately $70 million of the approximately $80 million in annualized ongoing net synergies we expect to achieve by the end of fiscal year 2022. · Cardiff Oncology ($CRDF) updated data from its Phase 1b/2 clinical trial for onvansertib in combination with standard-of-care (SOC) as second-line therapy in patients with KRAS-mutated metastatic colorectal cancer (mCRC); said as of data cut off July 2, 2021, eight of 19 (42%) patients who received the recommended Phase 2 dose of onvansertib 15 mg/m2 and were evaluable for disease response achieved a partial response · Turning Point Therapeutics ($TPTX) announces early clinical data for Repotrectinib in NTRK fusion-positive advanced solid tumors selected for late-breaker plenary presentation at 2021 AACR-NCI-EORTC conference · Beauty Health ($SKIN) announces $400M convertible senior notes offering Technology, Media & Telecom · Cisco ($CSCO) downgraded to Equal Weight from Overweight at Morgan Stanley · NetEase ($NTES) and Tencent (TCEHY) tumble again as China’s focus on reining in the power of tech companies hasn’t abated. A report in the South China Morning Post notes that the government will halt approvals for new online games. · Sea Limited ($SE) is looking to sell 11 million ADRs with the option to offer 1.65 million more as part of a so-called green shoe option; it is also raising $2.5 billion in a convertible bond that has a $375 million green shoe attached · SentinelOne ($S) Q2 revenue $45.8M vs. est. $40.4M; Q2 ARR up 127% YoY; total customer count grew more than 75% year-over-year to over 5,400 customers as of July 31; Customers with ARR over $100K grew 140% year-over-year to over 345 as of July 31, 2021; guides year revs $188M-$190M vs. est. $176.4M

125 Replies 9 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: bounces: $BIDU, $TME, $IQ ....others: $APTO, $PRQR, $AMC, $HOFV

54 Replies 12 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

watching $PRQR

73 Replies 8 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$PRQR looks tempting

112 Replies 8 👍 12 🔥

Key Metrics

Market Cap

45.78 M

Beta

0

Avg. Volume

1.25 M

Shares Outstanding

71.29 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on its unique proprietary RNA repair platform technologies, the Company is growing its pipeline with patients and loved ones in mind.

CEO: Daniel De Boer

Website:

HQ: Zernikedreef 9 Leiden, 2333 CK Zuid Holland

Related News